ArticleInternational journal of rheumatic diseases2019

Quantitative tracking of inflammatory activity at the peak and trough plasma levels of tofacitinib, a Janus kinase inhibitor, via in vivo

Sanchita Raychaudhuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.